Elana® Anastomotic System for CABG
Coronary Artery Bypass Graft (CABG) Surgery
Development/Pre-marketActive
Key Facts
Indication
Coronary Artery Bypass Graft (CABG) Surgery
Phase
Development/Pre-market
Status
Active
Company
About AMT Medical
AMT Medical is a private, pre-revenue medical device innovator focused on transforming coronary bypass surgery. Its core technology, the Elana® Anastomotic System, adapts a laser-based anastomosis platform from neurosurgery to create a standardized connection between a graft and a coronary artery on a beating heart. The company's mission is to drive the adoption of less invasive CABG techniques (like MIDCAB and TECAB) by reducing procedural complexity and dependence on high surgical skill. AMT Medical is in the development and regulatory phase, collaborating with leading European cardiac centers to advance its system toward clinical use.
View full company profileTherapeutic Areas
Other Coronary Artery Bypass Graft (CABG) Surgery Drugs
| Drug | Company | Phase |
|---|---|---|
| MAVERICS Graft System | Medical 21 | Pre-clinical |
| TxGuard Small Diameter Vascular Graft | Annoviant | Pre-clinical |